Table 2 Systolic and diastolic blood pressure (mmHg) during the intervention course.
Mean Systolic Blood Pressure (mmHg) | Mean Diastolic Blood Pressure (mmHg) | |||||||
|---|---|---|---|---|---|---|---|---|
Sequence AB (n = 9) | Sequence BA (n = 7) | Sequence AB (n = 9) | Sequence BA (n = 7) | |||||
Period 1 (Resveratrol) | Period 2 (Placebo) | Period 1 (Placebo) | Period 2 (Resveratrol) | Period 1 (Resveratrol) | Period 2 (Placebo) | Period 1 (Placebo) | Period 2 (Resveratrol) | |
Baseline | 142.2 (10.9) | 141.7(11.5) | 141.4 (9) | 130.6 (10.1) | 90.6 (9.8) | 89.4 (7.7) | 87.9 (6.8) | 85.1 (6.9) |
Week 1 | 142.7 (10.4) | 132.2 (10.7) | 134.1 (8.1) | 133.6 (12.8) | 88 (5.6) | 85.6 (6.9) | 86.4 (8.9) | 86.4 (5.4) |
Week 2 | 144.4 (9.7) | 136.9 (8.5) | 129.3 (7.2) | 137.9 (16.3) | 9.1 (3.5) | 85.3 (7.0) | 83.6 (5.7) | 87.5 (7.8) |
Week 3 | 139.6 (8.3) | 136.9 (12.0) | 132.4 (6.5) | 131.4 (7.3) | 87.5 (6.3) | 86.7 (4.8) | 82.9 (3.7) | 82.8 (3.0) |
Week 4 | 136.3 (5.2) | 135.0 (7.4) | 129.3 (11.7) | 132.5 (6.9) | 87.5 (5.3) | 86.9 (3.0) | 85.0 (5.0) | 84.7 (5.7) |
